Chengdi Yang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Genomics, phytochemicals, and oxidative stress
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Genomics, phytochemicals, and oxidative stress 3
- Circular RNAs in diseases 3
-
- Reproductive System and Pregnancy 2
- Biomarkers in Disease Mechanisms 1
- Co-authors
- Xiao Yang (8 shared papers)Jun Tao (8 shared papers)Wenbo Yuan (6 shared papers)Haiwei Yang (5 shared papers)Pengchao Li (6 shared papers)Jie Han (3 shared papers)Jingzi Wang (3 shared papers)Wei Zhang (3 shared papers)
- Journals
- Oncotarget (5 papers)Medicine (2 papers)Cellular Physiology and Biochemistry (2 papers)OncoTargets and Therapy (1 paper)Journal of Cancer (1 paper)
- Partner nations
- China
In The Last Decade
Chengdi Yang
19 papers receiving 937 citations
Chengdi Yang's Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 492
- Molecular Biology 714
- Nephrology 17
- Critical Care and Intensive Care Medicine 10
- Immunology 44
Countries citing papers authored by Chengdi Yang
This map shows the geographic impact of Chengdi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengdi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengdi Yang more than expected).
Fields of papers citing papers by Chengdi Yang
This network shows the impact of papers produced by Chengdi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengdi Yang. The network helps show where Chengdi Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengdi Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression Hit paper breakdown → | 2018 | 404 |
| 2 | 2018 | 125 | |
| 3 | 2017 | 81 | |
| 4 | 2017 | 60 | |
| 5 | 2017 | 36 | |
| 6 | 2016 | 30 | |
| 7 | 2017 | 28 | |
| 8 | 2006 | 26 | |
| 9 | 2017 | 26 | |
| 10 | 2017 | 23 | |
| 11 | 2016 | 22 | |
| 12 | 2016 | 17 | |
| 13 | 2023 | 16 | |
| 14 | 2016 | 12 | |
| 15 | 2017 | 11 | |
| 16 | 2017 | 9 | |
| 17 | 2017 | 7 | |
| 18 | 2017 | 6 | |
| 19 | 2024 | 5 |
About Chengdi Yang
Chengdi Yang is a scholar working on Molecular Biology, Immunology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 944 indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (3 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (2 papers), Reproductive System and Pregnancy (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), PARP inhibition in cancer therapy (1 paper), Biomarkers in Disease Mechanisms (1 paper) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Cancer Research (492 citations), Molecular Biology (714 citations), Nephrology (17 citations), Critical Care and Intensive Care Medicine (10 citations) and Immunology (44 citations). Chengdi Yang has collaborated with scholars based in China. Frequent co-authors include Xiao Yang, Jun Tao, Wenbo Yuan, Haiwei Yang, Pengchao Li, Jie Han, Jingzi Wang, Wei Zhang, Qiang Lv and Li Peng. Their work appears in journals such as Oncotarget, Medicine, Cellular Physiology and Biochemistry, OncoTargets and Therapy and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.